Porous Gold Nanoshells on Functional NH -MOFs: Facile Synthesis and Designable Platforms for Cancer Multiple Therapy
Overview
Authors
Affiliations
AuroShell nanoparticles (sealed gold nanoshell on silica) are the only inorganic materials that are approved for clinical trial for photothermal ablation of solid tumors. Based on that, porous gold nanoshell structures are thus critical for cancer multiple theranostics in the future owing to their inherent cargo-loading ability. Nevertheless, adjusting the diverse experimental parameters of the reported procedures to obtain porous gold nanoshell structures is challenging. Herein, a series of amino-functionalized porous metal-organic frameworks (NH -MOFs) nanoparticles are uncovered as superior templates for porous gold nanoshell deposition (NH -MOFs@Au ) by means of a more facile and general one-step method, which combines the enriched functionalities of NH -MOFs with those of porous gold nanoshells. Moreover, in order to illustrate the promising applications of this method in biomedicine, platinum nanozymes-encapsulated NH -MOFs are further designed with porous gold nanoshell coating and photosensitizer chlorin e6 (Ce6)-loaded nanoparticles with continuous O -evolving ability (Pt@UiO-66-NH @Au -Ce6). The combination of photodynamic and photothermal therapy is then carried out both in vitro and in vivo, achieving excellent synergistic therapeutic outcomes. Therefore, this work not only presents a facile strategy to fabricate functionalized porous gold nanoshell structures, but also illustrates an excellent synergistic tumor therapy strategy.
Zhang L, Chen X, Li R, Meng W, Huang G, Chen Y J Nanobiotechnology. 2025; 23(1):85.
PMID: 39910569 PMC: 11800444. DOI: 10.1186/s12951-025-03132-4.
Oxygen/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis.
Ma J, Qiu J, Wright G, Wang S Mol Pharm. 2024; 22(1):168-180.
PMID: 39571173 PMC: 11707740. DOI: 10.1021/acs.molpharmaceut.4c00817.
Singh P, Pandit S, Balusamy S, Madhusudanan M, Singh H, Amsath Haseef H Adv Healthc Mater. 2024; 14(4):e2403059.
PMID: 39501968 PMC: 11804848. DOI: 10.1002/adhm.202403059.
Akakuru O, Xing J, Huang S, Iqbal Z, Bryant S, Wu A Small. 2024; 21(10):e2404591.
PMID: 39210655 PMC: 11899496. DOI: 10.1002/smll.202404591.
Recent Progress and Prospect of Metal-Organic Framework-Based Nanozymes in Biomedical Application.
Baranwal A, Polash S, Kumar Aralappanavar V, Behera B, Bansal V, Shukla R Nanomaterials (Basel). 2024; 14(3).
PMID: 38334515 PMC: 10856890. DOI: 10.3390/nano14030244.